Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
0.6701
0.00 (0.00%)
At close: Jul 11, 2025, 4:00 PM
0.6700
-0.0001 (-0.01%)
After-hours: Jul 11, 2025, 7:52 PM EDT

Context Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020 2019
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
6094181042-
Upgrade
Market Cap Growth
149.16%422.07%73.39%-75.50%--
Upgrade
Enterprise Value
-2910-4-2963-
Upgrade
Last Close Price
0.671.051.130.652.66-
Upgrade
PB Ratio
0.660.991.520.300.88-
Upgrade
P/TBV Ratio
0.660.991.520.300.88-
Upgrade
Debt / Equity Ratio
0.000.00-0.00--0.65
Upgrade
Quick Ratio
47.0234.363.4511.0716.360.03
Upgrade
Current Ratio
48.8035.623.8311.8016.900.03
Upgrade
Return on Equity (ROE)
-55.59%-49.89%-102.79%-35.74%-53.50%-
Upgrade
Return on Assets (ROA)
-38.01%-32.76%-58.01%-20.84%-17.96%-433.97%
Upgrade
Return on Capital (ROIC)
-39.69%-34.84%-67.13%-22.39%-20.64%-
Upgrade
Earnings Yield
-45.97%-28.37%-132.83%-142.58%-24.63%-
Upgrade
FCF Yield
-25.40%-15.46%-116.66%-130.57%-20.72%-
Upgrade
Buyback Yield / Dilution
-389.92%-265.88%--463.44%-37.90%-
Upgrade
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q